Mode of cell death associated with adenovirus-mediated suicide gene therapy in HNSCC tumor model

Deepika Srivastava1, Ganesh Joshi, Kumaravel Somasundaram

  • 1ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai, 410210, India.

Anticancer Research
|November 24, 2011
PubMed
Abstract

Insights

Adenoviral-mediated suicide gene therapy using Herpes simplex virus thymidine kinase gene (HSVtk) and ganciclovir (GCV) does not primarily induce apoptosis in head and neck cancer cells. Further research is needed to understand the exact cell death mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Adenoviral-mediated suicide gene therapy demonstrates tumoricidal effects.
  • The precise molecular mechanisms of Herpes simplex virus thymidine kinase gene (HSVtk) and ganciclovir (GCV) induced cell death remain unclear.

Purpose of the Study:

  • To investigate the mode of cell death induced by adenoviral (Adv)-HSVtk/GCV treatment.
  • To elucidate the molecular pathways involved in cancer cell death.

Main Methods:

  • Utilized the head and neck squamous cell carcinoma cell line, NT8e.
  • Examined cell death mechanisms through gene expression analysis and cell cycle kinetics.

Main Results:

  • Cell death induced by Adv-HSVtk/GCV was independent of apoptotic gene expression.
  • Adv-HSVtk/GCV treatment led to S-phase accumulation without an increase in the sub-G1 population.
  • Cytoplasmic swelling suggested potential involvement of necrosis.

Conclusions:

  • Apoptosis may not be the primary mechanism of cell death in Adv-HSVtk/GCV treated NT8e cells.
  • Alternative cell death pathways should be explored for this gene therapy approach.

Related Concept Videos